Antithrombospondin Type-1 Domain-Containing 7A (THSD7A) Antibody, IgG with Reflex to Titer
Recommended for the evaluation of membranous nephropathy in at-risk patients who test negative for PLA2R antibodies.
Semi-Quantitative Indirect Fluorescent Antibody
New York DOH Approval Status
Serum Separator Tube
Separate serum from cells ASAP or within 2 hours of collection. Transfer 1 mL serum to an ARUP Standard Transport Tube. (Min: 0.2 mL)
Hemolyzed, hyperlipemic, icteric, heat-treated or contaminated
Ambient: 48 hours; Refrigerated: 2 weeks; Frozen: 1 month
Less than 1:10
This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the US Food and Drug Administration. This test was performed in a CLIA certified laboratory and is intended for clinical purposes.
Laboratory Developed Test (LDT)
If THSD7A Antibody, IgG is positive, then a THSD7A Antibody, IgG titer will be added. Additional charges apply.
86255; if reflexed, add 86256
|Component Test Code*||Component Chart Name||LOINC|
|3003478||THSD7A Ab, IgG, Screen||93339-0|